臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"liu y n"的相关文件

回到依作者浏览
依题名排序	依日期排序

显示项目 21-70 / 128 (共3页)
1 2 3 > >>
每页显示[10|25|50]项目

机构	日期	题名	作者
臺大學術典藏	2021-06-02T05:44:01Z	YC-1 [3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole] inhibits neointima formation in balloon-injured rat carotid through suppression of expressions and activities of matrix metalloproteinases 2 and 9	Liu Y.-N.; Pan S.-L.; Peng C.-Y.; JIH-HWA GUH; Huang D.-M.; Chang Y.-L.; Lin C.-H.; Pai H.-C.; Kuo S.-C.; Lee F.-Y.; Teng C.-M.
臺大學術典藏	2021-06-02T05:43:59Z	YC-1 inhibits HIF-1 expression in prostate cancer cells: Contribution of Akt/NF-κB signaling to HIF-1α accumulation during hypoxia	Sun H.-L.; Liu Y.-N.; Huang Y.-T.; Pan S.-L.; Huang D.-Y.; JIH-HWA GUH; Lee F.-Y.; Kuo S.-C.; Teng C.-M.
臺大學術典藏	2021-06-02T05:43:55Z	YC-1 induces heat shock protein 70 expression and prevents oxidized LDL-mediated apoptosis in vascular smooth muscle cells	Liu Y.-N.; Pan S.-L.; Peng C.-Y.; Huang D.-Y.; JIH-HWA GUH; Kuo S.-C.; Lee F.-Y.; Teng C.-M.
臺大學術典藏	2021-06-02T05:43:53Z	Evodiamine represses hypoxia-induced inflammatory proteins expression and hypoxia-inducible factor 1α accumulation in RAW264.7	Liu Y.-N.; Pan S.-L.; Liao C.-H.; Huang D.-Y.; JIH-HWA GUH; Peng C.-Y.; Chang Y.-L.; Teng C.-M.
臺大學術典藏	2021-06-02T05:43:52Z	Moscatilin repressed lipopolysaccharide-induced hif-1α accumulation and NF-κB activation in murine raw264.7 cells	Liu Y.-N.; Pan S.-L.; Peng C.-Y.; Huang D.-Y.; JIH-HWA GUH; Chen C.-C.; Shen C.-C.; Teng C.-M.
臺大學術典藏	2021-06-02T05:43:51Z	Moscatilin, a bibenzyl derivative from the India orchid Dendrobrium loddigesii, suppresses tumor angiogenesis and growth in vitro and in vivo	Tsai A.-C.; Pan S.-L.; Liao C.-H.; JIH-HWA GUH; Wang S.-W.; Sun H.-L.; Liu Y.-N.; Chen C.-C.; Shen C.-C.; Chang Y.-L.; Teng C.-M.
臺大學術典藏	2021-05-27T08:09:53Z	Akt activation correlates with snail expression and potentially determines the recurrence of prostate cancer in patients at stage T2 after a radical prostatectomy	Chen W.-Y.; KUO-TAI HUA; Lee W.-J.; Lin Y.-W.; Liu Y.-N.; Chen C.-L.; Wen Y.-C.; Chien M.-H.
臺大學術典藏	2021-05-02T03:49:13Z	miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-�eB Pathway	Liu Y.-N.;Tsai M.-F.;Wu S.-G.;Chang T.-H.;Tsai T.-H.;Gow C.-H.;Wang H.-Y.;Jin-Yuan Shih; Liu Y.-N.; Tsai M.-F.; Wu S.-G.; Chang T.-H.; Tsai T.-H.; Gow C.-H.; Wang H.-Y.; JIN-YUAN SHIH
臺大學術典藏	2021-04-29T05:08:48Z	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Kuan-Yu Chen;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; KUAN-YU CHEN; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2021-04-23T05:56:28Z	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Chih-Hsin Yang;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; CHIH-HSIN YANG; Yu C.-J.
臺大學術典藏	2021-03-13T03:29:30Z	Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations	YEN-FU CHEN; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; Tsai T.-H.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.
臺大學術典藏	2020-12-24T06:16:38Z	Two Frequent Mutations Associated with the Classic Form of Propionic Acidemia in Taiwan	Chiu Y.-H.; Liu Y.-N.; Liao W.-L.; Chang Y.-C.; Lin S.-P.; Hsu C.-C.; Chiu P.-C.; Niu D.-M.; Wang C.-H.; Ke Y.-Y.; YIN-HSIU CHIEN; Hsiao K.-J.; Liu T.-T.
臺大學術典藏	2020-12-24T06:16:34Z	Measuring propionyl-CoA carboxylase activity in phytohemagglutinin stimulated lymphocytes using high performance liquid chromatography	Hsiao K.-J.; Lee N.-C.; Chou Y.-Y.; YIN-HSIU CHIEN; Fan Y.-L.; Niu D.-M.; Liu T.-T.; Liu Y.-N.; Chiu Y.-H.
臺大學術典藏	2020-12-24T03:18:46Z	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Chia-Lin Hsu;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; CHIA-LIN HSU; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2020-12-09T01:38:22Z	Measuring propionyl-CoA carboxylase activity in phytohemagglutinin stimulated lymphocytes using high performance liquid chromatography	Liu T.-T.; Fan Y.-L.; Niu D.-M.; Chien Y.-H.; Chou Y.-Y.; NI-CHUNG LEE; Hsiao K.-J.; Chiu Y.-H.; Liu Y.-N.
臺大學術典藏	2020-12-02T02:34:23Z	Antitumor agents 268. Design, synthesis, and mechanistic studies of new 9-substituted phenanthrene-based tylophorine analogues as potent cytotoxic agents	Yang X.; Shi Q.; Liu Y.-N.; Zhao G.; Bastow K.F.; Lin J.-C.; Yang S.-C.; Pan-Chyr Yang; Lee K.-H.; Yang X.; Shi Q.; Liu Y.-N.; Zhao G.; Bastow K.F.; Lin J.-C.; Yang S.-C.; PAN-CHYR YANG; Lee K.-H.
臺大學術典藏	2020-12-02T02:33:45Z	Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations	Chen Y.-F.;Hsieh M.-S.;Wu S.-G.;Chang Y.-L.;Shih J.-Y.;Liu Y.-N.;Tsai M.-F.;Tsai T.-H.;Yu C.-J.;Yang J.C.-H.;PAN-CHYR YANG; Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; Tsai T.-H.; Yu C.-J.; Yang J.C.-H.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:33:23Z	The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients	Wu S-G.; Liu Y.-N.; Tsai M.-F.; Chang Y.-L.; Yu C.-J.; Pan-Chyr Yang; Yang J.C.-H.; Wen Y.-F.; Shih J.-Y.; Wu S-G.; Liu Y.-N.; Tsai M.-F.; Chang Y.-L.; Yu C.-J.; PAN-CHYR YANG; Yang J.C.-H.; Wen Y.-F.; Shih J.-Y.
臺大學術典藏	2020-12-02T02:33:21Z	Association of BIM deletion polymorphism with intrinsic resistance to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma	Shih J.-Y.; Wu S.-G.; Liu Y.-N.; Yu C.-J.; Pan-Chyr Yang; Shih J.-Y.; Wu S.-G.; Liu Y.-N.; Yu C.-J.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:33:14Z	Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C	Chang T.-H.; PAN-CHYR YANG et al.; Chang T.-H.; Tsai M.-F.; Gow C.-H.; Wu S.-G.; Liu Y.-N.; Chang Y.-L.; Yu S.-L.; Tsai H.-C.; Lin S.-W.; Chen Y.-W.; Kuo P.-Y.; Pan-Chyr Yang; Shih J.-Y.
臺大學術典藏	2020-08-13T06:33:46Z	Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations	Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; JIN-YUAN SHIH; Liu Y.-N.; Tsai M.-F.; Tsai T.-H.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.
臺大學術典藏	2020-08-13T06:33:44Z	IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer	JIN-YUAN SHIH; Yang J.C.-H.; Yu S.-L.; Liu Y.-N.; Chang T.-H.; Tsai M.-F.; Wu S.-G.; Tsai T.-H.; Chen H.-Y.
臺大學術典藏	2020-08-13T06:33:42Z	Discordant HER2 Exon 20 mutation status determines a differential sensitivity to Afatinib	Gow C.-H.; Liao W.-Y.; Liu Y.-N.; JIN-YUAN SHIH
臺大學術典藏	2020-08-13T06:33:35Z	Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C	Chang T.-H.;Tsai M.-F.;Gow C.-H.;Wu S.-G.;Liu Y.-N.;Chang Y.-L.;Yu S.-L.;Tsai H.-C.;Lin S.-W.;Chen Y.-W.;Kuo P.-Y.;Yang P.-C.;Jin-Yuan Shih; Wu S.-G.; Liu Y.-N.; Chang Y.-L.; Yu S.-L.; Tsai H.-C.; Lin S.-W.; Chen Y.-W.; Kuo P.-Y.; Yang P.-C.; JIN-YUAN SHIH; Chang T.-H.; Tsai M.-F.; Gow C.-H.
臺大學術典藏	2020-08-13T06:33:30Z	Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion	JIN-YUAN SHIH; Yang J.C.-H.; Yu C.-J.; Liu Y.-N.; Wu S.-G.; Wu S.-G.;Liu Y.-N.;Yu C.-J.;Yang J.C.-H.;Jin-Yuan Shih
臺大學術典藏	2020-08-13T06:33:30Z	Oncogenic Function of a KIF5B-MET Fusion Variant in Non-Small Cell Lung Cancer	JIN-YUAN SHIH; Gow C.-H.;Liu Y.-N.;Li H.-Y.;Hsieh M.-S.;Chang S.-H.;Luo S.-C.;Tsai T.-H.;Chen P.-L.;Tsai M.-F.;Jin-Yuan Shih; Gow C.-H.; Liu Y.-N.; Li H.-Y.; Hsieh M.-S.; Chang S.-H.; Luo S.-C.; Tsai T.-H.; Chen P.-L.; Tsai M.-F.
臺大學術典藏	2020-08-13T06:33:29Z	IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer	Hsu C.-L.; Liu Y.-N.; Tsai M.-F.; Chang T.-H.; Wu S.-G.; Wu S.-G.;Chang T.-H.;Tsai M.-F.;Liu Y.-N.;Hsu C.-L.;Chang Y.-L.;Yu C.-J.;Jin-Yuan Shih; Chang Y.-L.; Yu C.-J.; JIN-YUAN SHIH
臺大學術典藏	2020-08-13T06:33:27Z	Validation of immunohistochemistry for the detection of BRAF V600E-mutated lung adenocarcinomas	Gow C.-H.; Hsieh M.-S.; Lin Y.-T.; Liu Y.-N.; JIN-YUAN SHIH
臺大學術典藏	2020-08-13T06:33:26Z	The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism on Crizotinib-Treated Advanced EML4–ALK Rearranged Non-small Cell Lung Cancer	Lin Y.-T.;Liu Y.-N.;Jin-Yuan Shih; Lin Y.-T.; Liu Y.-N.; JIN-YUAN SHIH
臺大學術典藏	2020-08-13T06:33:26Z	Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer	Liu Y.-N.;Tsai M.-F.;Wu S.-G.;Chang T.-H.;Tsai T.-H.;Gow C.-H.;Chang Y.-L.;Jin-Yuan Shih; Liu Y.-N.; Tsai M.-F.; Wu S.-G.; Chang T.-H.; Tsai T.-H.; Gow C.-H.; Chang Y.-L.; JIN-YUAN SHIH
臺大學術典藏	2020-08-13T06:33:24Z	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Yu C.-J.; Yang J.C.-H.; JIN-YUAN SHIH; Lin C.-C.; Lee J.-H.; Hsu W.-H.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu C.-L.; Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Jin-Yuan Shih;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.
臺大學術典藏	2020-08-13T06:33:23Z	MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process	Wang H.-Y.; Liu Y.-N.; Wu S.-G.; Hsu C.-L.; Chang T.-H.; Tsai M.-F.; Lin Y.-T.; JIN-YUAN SHIH; Wang H.-Y.;Liu Y.-N.;Wu S.-G.;Hsu C.-L.;Chang T.-H.;Tsai M.-F.;Lin Y.-T.;Jin-Yuan Shih
臺大學術典藏	2020-08-13T06:33:22Z	Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer	JIN-YUAN SHIH; Yu C.-J.; Liu Y.-N.; Wu S.-G.; Tsai T.-H.; Lin Y.-T.; Lin Y.-T.;Tsai T.-H.;Wu S.-G.;Liu Y.-N.;Yu C.-J.;Jin-Yuan Shih
臺大學術典藏	2020-08-12T08:25:25Z	Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations	Tsai T.-H.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.; Chen Y.-F.; Hsieh M.-S.; SHANG-GIN WU; Chang Y.-L.; Shih J.-Y.; Liu Y.-N.; Tsai M.-F.
臺大學術典藏	2020-08-12T08:25:24Z	IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer	Chen H.-Y.; Yu S.-L.; Yang J.C.-H.; Shih J.-Y.; Tsai T.-H.; SHANG-GIN WU; Tsai M.-F.; Chang T.-H.; Liu Y.-N.
臺大學術典藏	2020-08-12T08:25:23Z	The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients	SHANG-GIN WU; Liu Y.-N.; Tsai M.-F.; Chang Y.-L.; Yu C.-J.; Yang P.-C.; Yang J.C.-H.; Wen Y.-F.; Shih J.-Y.
臺大學術典藏	2020-08-12T08:25:21Z	Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C	Chang T.-H.;Tsai M.-F.;Gow C.-H.;Shang-Gin Wu;Liu Y.-N.;Chang Y.-L.;Yu S.-L.;Tsai H.-C.;Lin S.-W.;Chen Y.-W.;Kuo P.-Y.;Yang P.-C.;Shih J.-Y.; Chang T.-H.; Tsai M.-F.; Gow C.-H.; SHANG-GIN WU; Liu Y.-N.; Chang Y.-L.; Yu S.-L.; Tsai H.-C.; Lin S.-W.; Chen Y.-W.; Kuo P.-Y.; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2020-08-12T08:25:21Z	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-sensitive Exon 19 Insertion and Exon 20 Insertion in Patients With Advanced Non-Small-cell Lung Cancer	Lin Y.-T.;Liu Y.-N.;Shang-Gin Wu;Yang J.C.-H.;Shih J.-Y.; Lin Y.-T.; Liu Y.-N.; SHANG-GIN WU; Yang J.C.-H.; Shih J.-Y.
臺大學術典藏	2020-08-12T08:25:19Z	IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer	Shang-Gin Wu;Chang T.-H.;Tsai M.-F.;Liu Y.-N.;Hsu C.-L.;Chang Y.-L.;Yu C.-J.;Shih J.-Y.; SHANG-GIN WU; Chang T.-H.; Tsai M.-F.; Liu Y.-N.; Hsu C.-L.; Chang Y.-L.; Yu C.-J.; Shih J.-Y.
臺大學術典藏	2020-08-12T08:25:18Z	MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process	Wang H.-Y.;Liu Y.-N.;Shang-Gin Wu;Hsu C.-L.;Chang T.-H.;Tsai M.-F.;Lin Y.-T.;Shih J.-Y.; Wang H.-Y.; Liu Y.-N.; SHANG-GIN WU; Hsu C.-L.; Chang T.-H.; Tsai M.-F.; Lin Y.-T.; Shih J.-Y.
臺大學術典藏	2020-08-12T08:25:17Z	Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer	Lin Y.-T.;Tsai T.-H.;Shang-Gin Wu;Liu Y.-N.;Yu C.-J.;Shih J.-Y.; Lin Y.-T.; Tsai T.-H.; SHANG-GIN WU; Liu Y.-N.; Yu C.-J.; Shih J.-Y.
臺大學術典藏	2020-08-12T06:34:10Z	Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer	Liu Y.-N.; CHONG-JEN YU; Shih J.-Y.; Lin Y.-T.;Tsai T.-H.;Wu S.-G.;Liu Y.-N.;Chong-Jen Yu;Shih J.-Y.; Lin Y.-T.; Tsai T.-H.; Wu S.-G.
臺大學術典藏	2020-08-12T02:50:36Z	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.; Wu C.-T.; Chang Y.-L.; Yang C.-Y.;Liao W.-Y.;Chao-Chi Ho;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; CHAO-CHI HO; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.
臺大學術典藏	2020-07-21T06:46:15Z	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.; Chang Y.-L.; Su K.-Y.; Hsu C.-L.; Liu Y.-N.; Chen K.-Y.; Tsai T.-H.; Liao W.-Y.; CHAO-CHI HO; Yang C.-Y.
臺大學術典藏	2020-07-21T06:25:18Z	Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations	Chen Y.-F.;Hsieh M.-S.;Wu S.-G.;Chang Y.-L.;Shih J.-Y.;Liu Y.-N.;Tsai M.-F.;Tzu-Hsiu Tsai;Yu C.-J.;Yang J.C.-H.;Yang P.-C.; Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; TZU-HSIU TSAI; Yu C.-J.; Yang J.C.-H.; Yang P.-C.
臺大學術典藏	2020-07-21T06:25:17Z	IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer	Shih J.-Y.; Liu Y.-N.;Chang T.-H.;Tsai M.-F.;Wu S.-G.;Tzu-Hsiu Tsai;Chen H.-Y.;Yu S.-L.;Yang J.C.-H.;Shih J.-Y.; Liu Y.-N.; Chang T.-H.; Tsai M.-F.; Wu S.-G.; TZU-HSIU TSAI; Chen H.-Y.; Yu S.-L.; Yang J.C.-H.
臺大學術典藏	2020-07-21T06:25:16Z	Oncogenic Function of a KIF5B-MET Fusion Variant in Non-Small Cell Lung Cancer	Shih J.-Y.; Gow C.-H.;Liu Y.-N.;Li H.-Y.;Hsieh M.-S.;Chang S.-H.;Luo S.-C.;Tzu-Hsiu Tsai;Chen P.-L.;Tsai M.-F.;Shih J.-Y.; Gow C.-H.; Liu Y.-N.; Li H.-Y.; Hsieh M.-S.; Chang S.-H.; Luo S.-C.; TZU-HSIU TSAI; Chen P.-L.; Tsai M.-F.
臺大學術典藏	2020-07-21T06:25:15Z	Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer	Liu Y.-N.;Tsai M.-F.;Wu S.-G.;Chang T.-H.;Tzu-Hsiu Tsai;Gow C.-H.;Chang Y.-L.;Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; Wu S.-G.; Chang T.-H.; TZU-HSIU TSAI; Gow C.-H.; Chang Y.-L.; Shih J.-Y.
臺大學術典藏	2020-07-21T06:25:14Z	Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer	TZU-HSIU TSAI; Wu S.-G.; Liu Y.-N.; Yu C.-J.; Shih J.-Y.; Lin Y.-T.; Lin Y.-T.;Tzu-Hsiu Tsai;Wu S.-G.;Liu Y.-N.;Yu C.-J.;Shih J.-Y.
臺大學術典藏	2020-07-21T06:09:11Z	Discordant HER2 Exon 20 mutation status determines a differential sensitivity to Afatinib	Liu Y.-N.; Shih J.-Y.; WEI-YU LIAO; Gow C.-H.

显示项目 21-70 / 128 (共3页)
1 2 3 > >>
每页显示[10|25|50]项目

	English \| 正體中文 \| 简体中文 \| 总笔数 :0
	造访人次 : 51762143 在线人数 : 1182 教育部委托研究计画计画执行:国立台湾大学图书馆